e-learning
resources
Munich 2014
Sunday, 07.09.2014
New insights into monocyte and macrophage biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Y. Kaku, H. Imaoka, Y. Morimatu, M. Matsuoka, H. Natori, M. Suetomo, T. Kawayama, T. Hoshino (Kurume, Japan)
Source:
International Congress 2014 – New insights into monocyte and macrophage biology
Session:
New insights into monocyte and macrophage biology
Session type:
Poster Discussion
Number:
1481
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kaku, H. Imaoka, Y. Morimatu, M. Matsuoka, H. Natori, M. Suetomo, T. Kawayama, T. Hoshino (Kurume, Japan). M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary. Eur Respir J 2014; 44: Suppl. 58, 1481
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Decreased FOXP3 expression in small airways of smokers with COPD
Source: Eur Respir J 2009; 33: 61-67
Year: 2009
Expression of muscarinic receptors by human macrophages
Source: Eur Respir J 2012; 39: 698-704
Year: 2012
Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Airway neutrophilia in COPD is not associated with increased neutrophil survival
Source: Eur Respir J 2006; 28: 1163-1169
Year: 2006
Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Mapping of eosinophil and basophils in COPD lung tissues
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept